Biotech Investors & VC Firms in Asia-Pacific
746 firms in this list, with a median first check of $500K. 161 of them lead rounds. Generated from verified public data and updated continuously.
Panda Capital
Seed–Late Stage
1 person
Shinhan Venture Investment
SeoulSeries A–Series B
1 person
Zhongguancun Development Group
BeijingPre-Seed–Growth
ABICO Asia Capital Corporation
TaipeiGrowth–Late Stage
1 person
Bio Sight Capital, Inc.
IbarakiSeed–Series A
1 person
Haibang Capital
HangzhouPre-Seed–Series A
1 person
Heights
Hong KongGrowth–Late Stage
1 person
Nissay Capital
TokyoPre-Seed–Growth
1 person
R3i Ventures
SingaporeGrowth–Late Stage
1 person
Aflac Ventures Japan
TokyoSeed–Growth
7 people
E-Crowd
Seed–Growth
Fosun Pharma
Shanghai
Hefei High-tech VC
HefeiSeed–Series C
JMCR Partners
Hong KongSeed–Late Stage
Seoul Investment Partners
SeoulSeed–Late Stage
Stonebridge Ventures
SeoulSeries A–Series C
3 people
The Wells Investment
SeoulSeed–Late Stage
TTM
Seed
UniQuest Extension Fund (UEF)
BrisbanePre-Seed–Seed
UNSW
SydneyPre-Seed–Seed
Ausvic Capital
Hong KongPre-Seed–Series A
Fshd Global Research Foundation
Sydney SouthSeed
IMM Investment
KangnamPre-Seed–Growth
Hiway Capital
GuangzhouSeed–Growth
Related lists
Investors & VC Firms in North America (13321)Investors & VC Firms in United States (12313)Investors & VC Firms in Europe (6087)AI & Machine Learning Investors & VC Firms (5355)Investors & VC Firms in Global (5320)Fintech Investors & VC Firms (5141)Healthtech Investors & VC Firms (4658)SaaS Investors & VC Firms (4528)Enterprise Software Investors & VC Firms (4426)Crypto & Web3 Investors & VC Firms (4140)
Data sourced from public filings and firms' own websites — see our methodology.


